MedTrace Logo

Transcorneal Electrical Stimulation Therapy for Retinal Disease

NCT00804102 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2012-05-04

No results posted yet for this study

Summary

Transcorneal stimulation may enable neurons to survive degeneration processes via enhanced secretion of neurotrophic substances and direct stimulation of neurons.

Conditions

  • Retinitis Pigmentosa
  • Macula Off
  • Primary Open Angle Glaucoma
  • Hereditary Macular Degeneration
  • Treated Retina Detachment
  • Retinal Artery Occlusion
  • Retinal Vein Occlusion
  • Non-Arthritic-Anterior-Ischemic Optic-Neuropathy
  • Hereditary Autosomal Dominant Optic Atrophy
  • Dry Age Related Macular Degeneration
  • Ischemic Macula Edema

Interventions

DEVICE

Transcorneal Electrical Stimulation

Neurostimulator drives Dawson-Trick-Litzkow electrode attached to patient eye. Different modi are used to stimulate patients.

DEVICE

DTL-electrode attached without energy

DTL-electrode attached to patient eye receives no energy from neurostimulator. Treatment times remain the same as used for each treatment arm.

Sponsors & Collaborators

  • Okuvision GmbH

    lead INDUSTRY

Principal Investigators

  • Florian Gekeler, MD, Prof · University-Eye-Hospital, Centre for Ophthalmology, D-72076 Tübingen, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2011-04-30
Completion
2011-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00804102 on ClinicalTrials.gov